Iovance Biotherapeutics IncNASDAQ:IOVA
- LAST PRICE11.8700
- TODAY'S CHANGE (%)0.2500 (2.1515%)
- Bid / Lots11.8200/ 1
- Ask / Lots11.8800/ 1
- Open / Previous Close11.7000 / 11.6200
- Day Range
- 52 Week Range
- Volume8,984,192
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | IOVA |
|---|---|---|
| 09:32 ET | 56950 | 11.7701 |
| 09:34 ET | 30300 | 11.9 |
| 09:36 ET | 123293 | 12 |
| 09:38 ET | 73987 | 12.03 |
| 09:39 ET | 68041 | 12.0536 |
| 09:41 ET | 36135 | 12.08 |
| 09:43 ET | 33937 | 12.05 |
| 09:45 ET | 70690 | 12.01 |
| 09:48 ET | 44464 | 12.045 |
| 09:50 ET | 24008 | 12.0383 |
| 09:52 ET | 28839 | 11.99 |
| 09:54 ET | 68111 | 11.87 |
| 09:56 ET | 102935 | 11.85 |
| 09:57 ET | 54509 | 11.885 |
| 09:59 ET | 177339 | 11.8572 |
| 10:01 ET | 88571 | 11.97 |
| 10:03 ET | 94006 | 12.18 |
| 10:06 ET | 112062 | 12.11 |
| 10:08 ET | 32628 | 12.06 |
| 10:10 ET | 35332 | 12.065 |
| 10:12 ET | 47895 | 12.16 |
| 10:14 ET | 64108 | 12.2 |
| 10:15 ET | 84267 | 12.1762 |
| 10:17 ET | 71441 | 12.13 |
| 10:19 ET | 50980 | 12.085 |
| 10:21 ET | 168435 | 12.15 |
| 10:24 ET | 55353 | 12.11 |
| 10:26 ET | 127354 | 12.2 |
| 10:28 ET | 19580 | 12.165 |
| 10:30 ET | 115787 | 12.28 |
| 10:32 ET | 74613 | 12.31 |
| 10:33 ET | 53576 | 12.33 |
| 10:35 ET | 62707 | 12.4114 |
| 10:37 ET | 50272 | 12.39 |
| 10:39 ET | 59677 | 12.29 |
| 10:42 ET | 47416 | 12.25 |
| 10:44 ET | 68449 | 12.28 |
| 10:46 ET | 54008 | 12.315 |
| 10:48 ET | 81414 | 12.2601 |
| 10:50 ET | 27425 | 12.19 |
| 10:51 ET | 21300 | 12.2323 |
| 10:53 ET | 49558 | 12.25 |
| 10:55 ET | 39222 | 12.295 |
| 10:57 ET | 45587 | 12.345 |
| 11:00 ET | 41092 | 12.32 |
| 11:02 ET | 39767 | 12.23 |
| 11:04 ET | 26356 | 12.29 |
| 11:06 ET | 17942 | 12.35 |
| 11:08 ET | 216494 | 12.37 |
| 11:09 ET | 22154 | 12.315 |
| 11:11 ET | 25119 | 12.265 |
| 11:13 ET | 13319 | 12.285 |
| 11:15 ET | 14698 | 12.33 |
| 11:18 ET | 19392 | 12.355 |
| 11:20 ET | 17218 | 12.335 |
| 11:22 ET | 10405 | 12.3 |
| 11:24 ET | 11208 | 12.345 |
| 11:26 ET | 20157 | 12.345 |
| 11:27 ET | 25806 | 12.33 |
| 11:29 ET | 146487 | 12.255 |
| 11:31 ET | 16113 | 12.2687 |
| 11:33 ET | 14028 | 12.25 |
| 11:36 ET | 21476 | 12.24 |
| 11:38 ET | 7809 | 12.2563 |
| 11:40 ET | 11954 | 12.26 |
| 11:42 ET | 9694 | 12.275 |
| 11:44 ET | 16370 | 12.28 |
| 11:45 ET | 25462 | 12.27 |
| 11:47 ET | 15694 | 12.27 |
| 11:49 ET | 26764 | 12.325 |
| 11:51 ET | 13670 | 12.3 |
| 11:54 ET | 7050 | 12.27 |
| 11:56 ET | 11310 | 12.28 |
| 11:58 ET | 5003 | 12.285 |
| 12:00 ET | 7791 | 12.27 |
| 12:02 ET | 12706 | 12.2 |
| 12:03 ET | 11352 | 12.25 |
| 12:05 ET | 4100 | 12.27 |
| 12:07 ET | 75618 | 12.29 |
| 12:09 ET | 13763 | 12.3 |
| 12:12 ET | 12475 | 12.33 |
| 12:14 ET | 34947 | 12.34 |
| 12:16 ET | 8039 | 12.3 |
| 12:18 ET | 14934 | 12.355 |
| 12:20 ET | 18100 | 12.37 |
| 12:21 ET | 24720 | 12.4 |
| 12:23 ET | 65133 | 12.38 |
| 12:25 ET | 12941 | 12.3597 |
| 12:27 ET | 21347 | 12.395 |
| 12:30 ET | 19880 | 12.405 |
| 12:32 ET | 34720 | 12.46 |
| 12:34 ET | 16582 | 12.4547 |
| 12:36 ET | 30810 | 12.47 |
| 12:38 ET | 10847 | 12.48 |
| 12:39 ET | 139654 | 12.4499 |
| 12:41 ET | 27301 | 12.43 |
| 12:43 ET | 43505 | 12.32 |
| 12:45 ET | 101694 | 12.3285 |
| 12:48 ET | 53850 | 12.29 |
| 12:50 ET | 71375 | 12.295 |
| 12:52 ET | 10459 | 12.295 |
| 12:54 ET | 380250 | 12.35 |
| 12:56 ET | 23780 | 12.26 |
| 12:57 ET | 24224 | 12.235 |
| 12:59 ET | 53224 | 12.21 |
| 01:01 ET | 28503 | 12.1658 |
| 01:03 ET | 23767 | 12.265 |
| 01:06 ET | 22734 | 12.25 |
| 01:08 ET | 11285 | 12.215 |
| 01:10 ET | 12056 | 12.225 |
| 01:12 ET | 10644 | 12.205 |
| 01:14 ET | 21343 | 12.18 |
| 01:15 ET | 10482 | 12.17 |
| 01:17 ET | 17316 | 12.145 |
| 01:19 ET | 46481 | 12.095 |
| 01:21 ET | 35175 | 12.045 |
| 01:24 ET | 16683 | 12.05 |
| 01:26 ET | 12722 | 12.055 |
| 01:28 ET | 13413 | 12.065 |
| 01:30 ET | 8875 | 12.035 |
| 01:32 ET | 25747 | 12.015 |
| 01:33 ET | 64672 | 12.02 |
| 01:35 ET | 25674 | 11.99 |
| 01:37 ET | 13072 | 12.005 |
| 01:39 ET | 5548 | 12.025 |
| 01:42 ET | 26509 | 11.9925 |
| 01:44 ET | 13085 | 11.995 |
| 01:46 ET | 11621 | 12.0184 |
| 01:48 ET | 57125 | 12.01 |
| 01:50 ET | 14737 | 12.02 |
| 01:51 ET | 14256 | 12.025 |
| 01:53 ET | 17647 | 12.025 |
| 01:55 ET | 9765 | 12.035 |
| 01:57 ET | 3849 | 12.035 |
| 02:00 ET | 26697 | 12.045 |
| 02:02 ET | 16288 | 12.005 |
| 02:04 ET | 7655 | 12.0199 |
| 02:06 ET | 60936 | 12.055 |
| 02:08 ET | 23143 | 11.99 |
| 02:09 ET | 19765 | 11.995 |
| 02:11 ET | 8082 | 11.99 |
| 02:13 ET | 23950 | 11.96 |
| 02:15 ET | 25370 | 11.945 |
| 02:18 ET | 9150 | 11.94 |
| 02:20 ET | 40185 | 11.94 |
| 02:22 ET | 12302 | 11.9585 |
| 02:24 ET | 29340 | 11.915 |
| 02:26 ET | 27250 | 11.93 |
| 02:27 ET | 6451 | 11.915 |
| 02:29 ET | 17227 | 11.885 |
| 02:31 ET | 26500 | 11.87 |
| 02:33 ET | 18555 | 11.865 |
| 02:36 ET | 33897 | 11.835 |
| 02:38 ET | 31419 | 11.875 |
| 02:40 ET | 23453 | 11.915 |
| 02:42 ET | 44738 | 11.895 |
| 02:44 ET | 12614 | 11.865 |
| 02:45 ET | 6835 | 11.885 |
| 02:47 ET | 18992 | 11.855 |
| 02:49 ET | 18800 | 11.855 |
| 02:51 ET | 8743 | 11.87 |
| 02:54 ET | 16106 | 11.865 |
| 02:56 ET | 14643 | 11.845 |
| 02:58 ET | 12264 | 11.835 |
| 03:00 ET | 13011 | 11.825 |
| 03:02 ET | 19092 | 11.82 |
| 03:03 ET | 8942 | 11.815 |
| 03:05 ET | 11383 | 11.815 |
| 03:07 ET | 24288 | 11.815 |
| 03:09 ET | 3674 | 11.815 |
| 03:12 ET | 22267 | 11.845 |
| 03:14 ET | 54450 | 11.86 |
| 03:16 ET | 25031 | 11.885 |
| 03:18 ET | 8753 | 11.865 |
| 03:20 ET | 12570 | 11.895 |
| 03:21 ET | 9633 | 11.915 |
| 03:23 ET | 11197 | 11.915 |
| 03:25 ET | 48832 | 11.9181 |
| 03:27 ET | 9790 | 11.915 |
| 03:30 ET | 22706 | 11.89 |
| 03:32 ET | 17598 | 11.87 |
| 03:34 ET | 34172 | 11.845 |
| 03:36 ET | 11227 | 11.865 |
| 03:38 ET | 54767 | 11.9052 |
| 03:39 ET | 19991 | 11.92 |
| 03:41 ET | 62272 | 11.865 |
| 03:43 ET | 54991 | 11.81 |
| 03:45 ET | 121493 | 11.785 |
| 03:48 ET | 36604 | 11.83 |
| 03:50 ET | 28587 | 11.815 |
| 03:52 ET | 26725 | 11.825 |
| 03:54 ET | 45485 | 11.825 |
| 03:56 ET | 40308 | 11.845 |
| 03:57 ET | 71601 | 11.835 |
| 03:59 ET | 717016 | 11.87 |
Aug 16, 2024
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4), from 5:00PM ET on Friday Aug 16, 2024 by Dow Jones
5:00PM ET on Friday Aug 16, 2024 by Dow Jones
Aug 12, 2024
DJ Iovance Biotherapeutics Price Target Maintained With a $32.00/Share by HC Wainwright & Co., from 6:34AM ET on Monday Aug 12, 2024 by Dow Jones
6:34AM ET on Monday Aug 12, 2024 by Dow Jones
Aug 9, 2024
DJ Iovance Biotherapeutics Shares Rise 27% After 2Q Revenue Beat, from 6:38AM ET on Friday Aug 09, 2024 by Dow Jones
6:38AM ET on Friday Aug 09, 2024 by Dow Jones
Aug 8, 2024
*DJ Iovance Biotherapeutics 2Q Loss/Shr 34c >IOVA, from 4:01PM ET on Thursday Aug 08, 2024 by Dow Jones
4:01PM ET on Thursday Aug 08, 2024 by Dow JonesIovance Biotherapeutics Reports Financial Results and Corporate Updates for Second Quarter and First Half 2024, from 4:01PM ET on Thursday Aug 08, 2024 by Dow Jones
4:01PM ET on Thursday Aug 08, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Iovance Biotherapeutics Inc | 3.5B | -7.1x | --- |
Biohaven Ltd | 3.8B | -4.6x | --- |
Merus NV | 3.6B | -18.7x | --- |
MoonLake Immunotherapeutics | 3.1B | -55.0x | --- |
IDEAYA Biosciences Inc | 3.2B | -18.1x | --- |
Vitaspring Biomedical Co. Ltd | 3.1B | 3,311.3x | --- |
Company Information
Iovance Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company develops and delivers tumor infiltrating lymphocyte (TIL), therapies for patients with solid tumor cancers. Its lead product candidate, Amtagvi (lifileucel), is a tumor-derived autologous T cell immunotherapy indicated for the treatment of adult patients with unresectable or metastatic melanoma previously treated with a PD-1 blocking antibody, and if BRAF V600 mutation positive, a BRAF inhibitor with or without a MEK inhibitor. The Company also marketing Proleukin (aldesleukin), aninterleukin-2, or IL-2, product used in the Amtagvi treatment regimen. Its development pipeline includes multicenter trials of TIL cell therapies in additional treatment settings for solid tumor cancers. Amtagvi and Proleukin are part of a treatment regimen that also includes lymphodepletion. The Company is also developing next generation therapies using TIL, such as genetically modified TIL cell therapy.
Contact Information
- Headquarters
- 825 INDUSTRIAL ROAD, 4TH FLOORSAN CARLOS, CA, United States 94070
- Phone
- 650-260-7120
- Fax
- 302-697-4597
Executives
- Independent Chairman of the Board
- Iain Dukes
- Interim President, Interim Chief Executive Officer, General Counsel, Corporate Secretary
- Frederick Vogt
- Chief Financial Officer
- Jean-Marc Bellemin
- Chief Operating Officer
- Igor Bilinsky
- Chief Medical Officer
- Friedrich Graf Finckenstein
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $3.5B |
|---|---|
Revenue (TTM) | $32.8M |
Shares Outstanding | 303.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.59 |
EPS | $-1.68 |
Book Value | $2.28 |
P/E Ratio | -7.1x |
Price/Sales (TTM) | 107.6 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -1,401.36% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
